Burt Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$9K 109
2020
Q4
$9K Buy
+100
New +$7.97K ﹤0.01% 284

Other funds holding ARKG

Burt Wealth Advisors's ARKG Position: Q1 2021 in Review

Burt Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 100 shares — an estimated $9K sold.

Burt Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

  • Burt Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
  • Burt Wealth Advisors sold 100 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $9K.
  • Burt Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 1 quarter.
  • Burt Wealth Advisors's ARK Genomic Revolution ETF position peaked at $9K in Q4 2020.
  • 505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on Burt Wealth Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.